McGuire S (2014) Institute of Medicine
New research has found that semaglutide, a popular medication used to treat diabetes and obesity, may help protect kidney function in people who have excess weight and cardiovascular disease (CVD)
Whilst Ozempic itself does not appear as a measurable substance in standard blood tests, it significantly influences metabolic parameters such as HbA1c, kidney function markers, and lipid profiles
Similar results were found in a clinical study in patients with T2DM, where administration of liraglutide, but not metformin, increased the relative abundance of Akkermansia , which is often associated with the improvement of gastric mucosa and also becomes severely depleted in diabetic patients [115]
Day 2 added two favorable outcomes
Skin looks slightly brighter 2